Analytical Data
-
基因名
FASTK
- Application
-
别名
FASTK；Fas-activated serine/threonine kinase
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q14296
-
表达区间
1-549aa
-
氨基酸序列
MRRPRGEPGP RAPRPTEGAT CAGPGESWSP SPNSMLRVLL SAQTSPARLS GLLLIPPVQP CCLGPSKWGD RPVGGGPSAG PVQGLQRLLE QAKSPGELLR WLGQNPSKVR AHHYSVALRR LGQLLGSRPR PPPVEQVTLQ DLSQLIIRNC PSFDIHTIHV CLHLAVLLGF PSDGPLVCAL EQERRLRLPP KPPPPLQPLL RGGQGLEAAL SCPRFLRYPR QHLISSLAEA RPEELTPHVM VLLAQHLARH RLREPQLLEA IAHFLVVQET QLSSKVVQKL VLPFGRLNYL PLEQQFMPCL ERILAREAGV APLATVNILM SLCQLRCLPF RALHFVFSPG FINYISGTPH ALIVRRYLSL LDTAVELELP GYRGPRLPRR QQVPIFPQPL ITDRARCKYS HKDIVAEGLR QLLGEEKYRQ DLTVPPGYCT DFLLCASSSG AVLPVRTQDP FLPYPPRSCP QGQAASSATT RDPAQRVVLV LRERWHFCRD GRVLLGSRAL RERHLGLMGY QLLPLPFEEL ESQRGLPQLK SYLRQKLQAL GLRWGPEGG
-
分子量
84 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The field of protein research has witnessed significant advancements in recent years, particularly in the study of recombinant proteins, which are crucial for various applications in biotechnology and medicine. FASTK (Fatty Acid Synthase Kinase) is an enzyme implicated in the regulation of mitochondrial function, energy metabolism, and apoptosis. With its multifaceted roles in cellular processes, understanding FASTK's structure and function through recombinant protein technology is essential. Researchers aim to elucidate the molecular mechanisms by which FASTK influences metabolic pathways and its potential impact on diseases, including cancer and metabolic disorders. By utilizing recombinant DNA technology, scientists can produce FASTK in large quantities, enabling detailed biochemical studies, structural analysis, and the exploration of its interactions with other biomolecules. This research not only enhances our understanding of FASTK's biological significance but also opens avenues for therapeutic interventions targeting metabolic diseases and mitochondrial dysfunctions. Furthermore, the use of recombinant FASTK in drug development may provide novel strategies for managing conditions linked to energy metabolism imbalances, highlighting the importance of this area of study in both fundamental and applied sciences.
